Carlsbad-based GenMark Diagnostics, the developer of molecular diagnostics testing systems, reported this morning that it is in a licensing agreement with PerkinElemer. GenMark said it has been granted a non-exclusive license to PerkinElmer's microfluidics patent portfolio. Financial terms of the deal were not disclosed. GenMark said the deal will provide it with "maximum flexibility" to expand its platform.
Top NewsThursday, March 29, 2012
GenMark In Patent Deal With PerkinElmer